Pelvic inflammatory disease diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
m Bot: Removing from Primary care |
|||
(3 intermediate revisions by 2 users not shown) | |||
Line 4: | Line 4: | ||
==Diagnostic Criteria== | ==Diagnostic Criteria== | ||
[[CDC]] has developed a diagnostic criteria for prompt treatment of PID based on clinical manifestations to minimize its sequelae.<ref name="pmid26042815">{{cite journal |vauthors=Workowski KA, Bolan GA |title=Sexually transmitted diseases treatment guidelines, 2015 |journal=MMWR Recomm Rep |volume=64 |issue=RR-03 |pages=1–137 |year=2015 |pmid=26042815 |doi= |url=}}</ref> | The [[CDC]] has developed a set of diagnostic criteria for prompt treatment of PID based on clinical manifestations to minimize its sequelae.<ref name="pmid26042815">{{cite journal |vauthors=Workowski KA, Bolan GA |title=Sexually transmitted diseases treatment guidelines, 2015 |journal=MMWR Recomm Rep |volume=64 |issue=RR-03 |pages=1–137 |year=2015 |pmid=26042815 |doi= |url=}}</ref> | ||
{| style="border: 0px; font-size: 100%; margin: 3px;" align=center | {| style="border: 0px; font-size: 100%; margin: 3px;" align=center | ||
Line 24: | Line 24: | ||
*Elevated [[erythrocyte sedimentation rate]] | *Elevated [[erythrocyte sedimentation rate]] | ||
*Elevated [[C-reactive protein]] | *Elevated [[C-reactive protein]] | ||
*Laboratory documentation of cervical infection [[N. gonorrhoeae]] or [[C. trachomatis]] | *Laboratory documentation of cervical infection ([[N. gonorrhoeae]] or [[C. trachomatis]]) | ||
| style="padding: 10px 10px; background: #F5F5F5;" | | | style="padding: 10px 10px; background: #F5F5F5;" | | ||
*[[Endometrial biopsy]] with histopathological evidence of [[endometritis]] | *[[Endometrial biopsy]] with histopathological evidence of [[endometritis]] | ||
*[[Transvaginal ultrasound]] or [[MRI]] showing thickened, fluid-filled tubes with or without free pelvic fluid or tubo-ovarian complex, or [[doppler]] studies suggesting pelvic infection (e.g., tubal [[Hyperaemia|hyperemia]] | *[[Transvaginal ultrasound]] or [[MRI]] showing thickened, fluid-filled tubes with or without free pelvic fluid or tubo-ovarian complex, or [[doppler]] studies suggesting pelvic infection (e.g., tubal [[Hyperaemia|hyperemia]]) | ||
*Laporoscopic findings consistent with PID | *Laporoscopic findings consistent with PID | ||
|- | |- | ||
Line 39: | Line 39: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Gynecology]] |
Latest revision as of 23:37, 29 July 2020
Pelvic inflammatory disease Microchapters |
Differentiating Pelvic Inflammatory Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Pelvic inflammatory disease diagnostic criteria On the Web |
American Roentgen Ray Society Images of Pelvic inflammatory disease diagnostic criteria |
Risk calculators and risk factors for Pelvic inflammatory disease diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Diagnostic Criteria
The CDC has developed a set of diagnostic criteria for prompt treatment of PID based on clinical manifestations to minimize its sequelae.[1]
Minimum diagnostic criteria
(at least 1 must be present) |
Additional diagnostic criteria
(at least 1 must be present), increases specificity |
Definitive diagnostic criteria |
---|---|---|
|
|
|
- The minimum diagnostic criteria are intended to have a high sensitivity with the goal of detecting as many cases of PID as possible.
- Additional criteria support the diagnosis of PID with greater specificity, while definitive criteria confirm the diagnosis.[1]